How should risk stratification be performed in an adult with non‑traumatic chest pain?

Risk Stratification in Nontraumatic Chest Pain

All patients presenting with nontraumatic chest pain should undergo immediate risk stratification using a structured approach that includes: 1) 12-lead ECG within 10 minutes of arrival, 2) high-sensitivity cardiac troponin measurement at presentation and 2-3 hours later, 3) clinical assessment using validated risk scores (HEART score preferred), and 4) classification into high, intermediate, or low risk categories to guide disposition and further testing.

Initial Evaluation Components

The risk stratification process must simultaneously answer two critical questions 1, 2, 3:

• What is the likelihood of acute coronary syndrome (ACS)?
• What is the likelihood of adverse cardiovascular outcomes (death, MI, stroke, heart failure, serious arrhythmia)?

Immediate Actions (Within 10 Minutes)

12-Lead ECG: Must be performed and reviewed by an experienced physician within 10 minutes of emergency department arrival 1, 2, 4. If initial ECG is nondiagnostic but clinical suspicion remains high, obtain serial ECGs at 15-30 minute intervals 1, 2.

Cardiac Biomarkers: High-sensitivity cardiac troponin (hs-cTn) is the preferred marker and should be measured in all patients 1, 2. For patients with negative biomarkers within 6 hours of symptom onset, remeasure at 8-12 hours 1, 2.

Risk Classification Framework

High-Risk Features (Require Immediate Intervention)

Patients with any of the following require urgent management 1, 2, 3:

History/Clinical:

• Prolonged ongoing rest pain (>20 minutes)
• Hemodynamic instability (hypotension, pulmonary edema)
• New or worsening mitral regurgitation murmur
• S3 gallop or new/worsening rales
• Early post-infarction unstable angina

ECG Findings:

• Transient ST-segment elevation or depression ≥0.5 mm
• New or presumed new bundle branch block
• Sustained ventricular tachycardia

Biomarkers:

• Elevated cardiac troponin (e.g., >0.1 ng/mL)

High-risk patients require:

• Immediate cardiology consultation
• Coronary angiography within 24-48 hours (or within 1 hour if severe ongoing ischemia, major arrhythmias, or hemodynamic instability) 5
• Initiation of antiplatelet therapy, anticoagulation, and consideration of GPIIb/IIIa inhibitors 5

Intermediate-Risk Features

Patients with these characteristics require observation and serial testing 1, 2, 3:

History:

• Prior MI, peripheral/cerebrovascular disease, or CABG
• Prolonged rest angina (>20 minutes), now resolved
• Nocturnal angina
• Age >70 years

ECG:

• T-wave changes
• Pathological Q waves
• Resting ST-depression <1 mm in multiple leads

Biomarkers:

• Slightly elevated troponin (e.g., 0.01-0.1 ng/mL)

Management approach 6:

• Repeat hs-cTn at 3-6 hours
• Apply HEART score for further stratification
• Consider observation unit placement
• Noninvasive testing (stress imaging or coronary CT angiography) within 24 hours to 7 days 7

Low-Risk Features

Patients meeting all of the following can be considered for early discharge 1, 2, 3:

History:

• New-onset or progressive angina (2 weeks to 2 months)
• Increased angina frequency but no prolonged rest pain
• Age <75 years

ECG:

• Normal or unchanged from baseline

Biomarkers:

• Normal troponin levels on serial testing

Validated Risk Scores

HEART Score (Preferred)

The HEART score demonstrates superior performance for identifying low-risk patients 8, 9, 10:

Components:

• History (0-2 points)
• ECG findings (0-2 points)
• Age (0-2 points)
• Risk factors (0-2 points)
• Troponin (0-2 points)

Interpretation:

• Score 0-3: Low risk (1% 30-day MACE rate) - safe for discharge with outpatient follow-up 8, 9
• Score 4-6: Intermediate risk - requires observation and further testing
• Score 7-10: High risk - requires admission and invasive evaluation

The HEART score with cutoff ≤3 identifies the greatest proportion of patients at low risk while maintaining high sensitivity (94.7%) and specificity (84.1%) 8, 9.

Modified HEART Score

The mHEART score shows comparable or superior performance (AUC 0.891) and identifies 51% of patients as low risk with 99% negative predictive value 10. When combined with serial hs-cTn testing, it allows discharge of approximately 50% of patients with only 0.5% MACE miss-rate 10.

High-Sensitivity Troponin Protocols

0/2-Hour Protocol

For patients presenting ≥3 hours after symptom onset 6:

Rule-out criteria (hs-cTnI):

• Initial value <5 ng/L AND
• 2-hour value <5 ng/L AND
• Delta change <3 ng/L

Rule-out criteria (hs-cTnT):

• Initial value <6 ng/L AND
• 2-hour value <6 ng/L

Patients meeting these criteria have very low 30-day MACE risk and can be discharged with outpatient follow-up 6, 11.

0/3-Hour Protocol (HIGH-STEACS)

Alternative pathway for symptom onset ≥3 hours 6:

• Single hs-cTn below validated threshold can rule out ACS
• Requires nonischemic ECG
• Allows immediate discharge in appropriate patients

Additional Diagnostic Considerations

Non-Cardiac Life-Threatening Causes

Must rule out 7, 4:

• Acute aortic syndrome: Expedited CT angiography if suspected (ripping pain radiating to back, pulse differential)
• Pulmonary embolism: Apply Wells criteria; obtain CT pulmonary angiography if indicated
• Tension pneumothorax: Clinical diagnosis with immediate intervention
• Esophageal rupture: Consider in appropriate clinical context

Imaging Recommendations

Chest X-ray: First-line imaging for all patients to evaluate non-coronary causes 7

Coronary CT Angiography (CCTA): For low-risk patients with negative troponins and nonischemic ECG, CCTA within 24 hours to 7 days provides excellent risk stratification and guides preventive therapy 7, 4

Transthoracic Echocardiography: Useful for assessing wall motion abnormalities, valvular disease, and alternative diagnoses 7

Disposition Algorithm

Immediate PCI (<90 minutes): STEMI patients 7

Early PCI (<24 hours): Very high-risk NSTE-ACS patients 7

Observation with serial testing: Intermediate-risk patients 6

Discharge with outpatient follow-up (1-2 weeks): Low-risk patients with:

• HEART score ≤3 OR
• Negative serial hs-cTn at 0/2 hours OR
• Recent normal stress test (<1 year) or coronary angiography showing no obstructive disease 4, 11

Critical Pitfalls to Avoid

Do not rely on traditional risk factors alone - symptoms, ECG, and biomarkers are more predictive than diabetes, hypertension, or family history in acute presentations 1, 3.

Do not delay reperfusion therapy waiting for biomarker results in patients with diagnostic ECG changes 1, 12.

Do not discharge patients with ongoing symptoms even if initial testing is negative - serial evaluation is mandatory 1, 2.

Do not routinely perform stress testing in low-risk patients who have been ruled out by hs-cTn protocols - MACE risk is sufficiently low that additional testing adds minimal value 11, 8.

Recognize atypical presentations - elderly patients, women, and diabetics may present with dyspnea, nausea, or fatigue rather than classic chest pain 4, 13.